WITTER MALCOLM G received a stock award from NAVIDEA BIOPHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/1/2022ACC: 0001437749-22-021742
Director
Since Dec 2020
+2.73K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
2.73K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.50K
Price / share
—
Trade value
—
% of position
1.6%
8/31/2022
156.39K→158.89K
Total
Net shares
+2.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/31/2022 | A · Award | +2.50K | — | — | 1.6% | 156.39K | 158.89K |
| Total | +2.50K | $0.00 | ||||||
Derivative Transactions2
Series I Convertible Preferred Stock
Direct
Converts to
Common Stock
255.53K shares
Shares
+115.00
Strike price
0.45
Held after
115.00
Exercisable
—
8/30/2022
Warrant to Purchase Common Stock
Direct
Converts to
Common Stock
255.53K shares
Shares
+115.00
Strike price
0.50
Held after
115.00
Exercisable
—
8/30/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series I Convertible Preferred Stock Direct | Common Stock255.53K shares | 8/30/2022 | P · Purchase | +115.00 | 0.45 | — | 115.00 |
| Warrant to Purchase Common Stock Direct | Common Stock255.53K shares | 8/30/2022 | P · Purchase | +115.00 | 0.50 | — | 115.00 |